====== Modified Glasgow prognostic score ======

https://www.mdcalc.com/modified-glasgow-prognostic-score-mgps-cancer-outcomes
----


The modified Glasgow prognostic score (mGPS), a combination of [[C-reactive protein]] (CRP) and [[albumin]] levels, reflects systemic [[inflammation]] and nutritional status. This [[score]] has been shown to have a [[prognosis]] value for various [[tumor]]s.

pre-radiosurgical mGPS and [[Neutrophil-to-Lymphocyte Ratio]] (NLR) groups seem to be the most effective and simple independent prognostic factors to predict [[clinical outcome]] in radiosurgically treated BM patients
((Cho A, Untersteiner H, Fitschek F, Khalaveh F, Pruckner P, Pavo N, Rössler K, Dorfer C, Gatterbauer B, Höller C, Schmidinger M, Frischer JM. The clinical [[relevance]] of [[laboratory]] prognostic scores for patients with radiosurgically treated [[brain metastases]] of non-pulmonary primary tumor. J Neurooncol. 2021 Jun 20. doi: 10.1007/s11060-021-03788-6. Epub ahead of print. PMID: 34148164.))

[[Neutrophil-to-Lymphocyte Ratio]] (NLR), [[Platelet-to-Lymphocyte Ratio]] (PLR), [[Lymphocyte-to-Monocyte Ratio]] (LMR) and mGPS represent effective and simple tools to predict survival in [[NSCLC]] patients prior to radiosurgery for brain metastases
((Cho A, Untersteiner H, Hirschmann D, Fitschek F, Dorfer C, Rössler K,
Zöchbauer-Müller S, Gatterbauer B, Hochmair MJ, Frischer JM. Pre-radiosurgery
leucocyte ratios and [[modified glasgow prognostic score]] predict survival in [[non-
small cell lung cancer]] brain metastases patients. J Neurooncol. 2021
Jan;151(2):257-265. doi: 10.1007/s11060-020-03660-z. Epub 2020 Nov 11. PMID:
33179214; PMCID: PMC7875838.))